
    
      The BAROSTIM NEO Hypertension Trial is a prospective, randomized, controlled trial assessing
      the safety and efficacy of the BAROSTIM NEO System in subjects with resistant hypertension.

      All subjects are now in long term follow-up and are required to have at least one annual
      visit.

      Parameters assessed during visits are:

        -  Office Cuff Blood Pressure

        -  Physical Assessment

        -  Subject Medications

        -  Serious adverse events
    
  